Application of Minimal Anticipated Biological Effect Level (MABEL) in Human Starting Dose Selection for Immunomodulatory Protein Therapeutics – Principles and Case Studies
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
44
References
0
Citations
NaN
KQI